Business Wire

Business Wire is the global leader in news release distribution and regulatory disclosure. Business Wire delivers news and multimedia directly into editorial systems and leading online news platforms and is a trusted source for news organisations, journalists, investment professionals and regulatory authorities.
Results: 1621-1632 of 22360

Meiji Seika Pharma: Positive Results from the Phase III Integral-1 Trial of Nacubactam, a Novel β-Lactamase Inhibitor, in Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis ― Published in The Lancet

First Trust Global Portfolios Management Limited Announces Distribution for certain sub-funds of First Trust Global Funds ICAV

Xsolla and Skich Announce Strategic Partnership to Bring Merchant of Record Payments to an Alternative Mobile Game Marketplace

Boomi and Guru Partner to Deliver AI-Powered Enterprise Knowledge Enriched by Real-Time Data Activation

True Adds Consumer and Enterprise Growth Leader Michael McGoohan as Managing Director Across CEO, Board and Consumer Practices






